202 related articles for article (PubMed ID: 15574784)
1. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
Smith HJ; Wyke SM; Tisdale MJ
Cancer Res; 2004 Dec; 64(23):8731-5. PubMed ID: 15574784
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Smith HJ; Mukerji P; Tisdale MJ
Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
Mirza KA; Pereira SL; Voss AC; Tisdale MJ
Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.
Whitehouse AS; Tisdale MJ
Br J Cancer; 2003 Sep; 89(6):1116-22. PubMed ID: 12966435
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes.
Smith HJ; Tisdale MJ
Br J Cancer; 2003 Nov; 89(9):1783-8. PubMed ID: 14583784
[TBL] [Abstract][Full Text] [Related]
6. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
Wyke SM; Russell ST; Tisdale MJ
Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.
Wyke SM; Tisdale MJ
Br J Cancer; 2005 Feb; 92(4):711-21. PubMed ID: 15714207
[TBL] [Abstract][Full Text] [Related]
9. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.
Whitehouse AS; Khal J; Tisdale MJ
Br J Cancer; 2003 Aug; 89(4):737-45. PubMed ID: 12915888
[TBL] [Abstract][Full Text] [Related]
10. Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes.
Smith HJ; Wyke SM; Tisdale MJ
Br J Cancer; 2004 May; 90(9):1850-7. PubMed ID: 15150589
[TBL] [Abstract][Full Text] [Related]
11. Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes.
Wyke SM; Khal J; Tisdale MJ
Cell Signal; 2005 Jan; 17(1):67-75. PubMed ID: 15451026
[TBL] [Abstract][Full Text] [Related]
12. Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II.
Russell ST; Eley H; Tisdale MJ
Cell Signal; 2007 Aug; 19(8):1797-806. PubMed ID: 17532611
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Eley HL; Russell ST; Tisdale MJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1417-26. PubMed ID: 18840762
[TBL] [Abstract][Full Text] [Related]
14. β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.
Girón MD; Vílchez JD; Shreeram S; Salto R; Manzano M; Cabrera E; Campos N; Edens NK; Rueda R; López-Pedrosa JM
PLoS One; 2015; 10(2):e0117520. PubMed ID: 25658432
[TBL] [Abstract][Full Text] [Related]
15. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
Wyke SM; Tisdale MJ
Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
17. Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.
Mirza KA; Tisdale MJ
Br J Cancer; 2014 Aug; 111(5):903-8. PubMed ID: 25101564
[TBL] [Abstract][Full Text] [Related]
18. β-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat.
Noh KK; Chung KW; Choi YJ; Park MH; Jang EJ; Park CH; Yoon C; Kim ND; Kim MK; Chung HY
PLoS One; 2014; 9(7):e102947. PubMed ID: 25032690
[TBL] [Abstract][Full Text] [Related]
19. β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells.
Kimura K; Cheng XW; Inoue A; Hu L; Koike T; Kuzuya M
Nutr Res; 2014 Apr; 34(4):368-74. PubMed ID: 24774073
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Sanders PM; Russell ST; Tisdale MJ
Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
